verapamil has a significant prolactin releasing effect - a study revealed that 8.5% of male patients treated with verapamil had increased prolactin levels with a concomitant reduction in testosterone levels (1) - this prolactin releasing effect is not significant with other calcium antagonists
verapamil may lead to hyperprolactinaemia via antagonism of N-type calcium channels and consequent decrease in central dopamine production
Reference:
1) Romeo JH et al. Hyperprolactinaemia and verapamil: prevalence and potential association with hypogonadism in men. Clin Endocrinol (Oxf) 1996;45:571-5.
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page